GHDDI and Microsoft Research's Center for Scientific Intelligence enter into a partnership, joining forces to revolutionize and empower new drug development through AI

Global Health Drug Discovery and Development (GHDDI) and Microsoft Research AI4Science have announced a collaboration in which they will work together to develop generative artificial intelligence and fundamental big model technologies in the field of global health infectious diseases. The main goal of this collaboration is to apply AI technologies to new drug discovery and development in order to enable a full chain of workflows from virtual generation and screening of compounds, to synthesis and optimization, to biological experimental validation, to iterative AI upgrades.